标题
CAR-NK cells: a promising cellular immunotherapy in lymphoma
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 23, Issue 1, Pages 37-47
出版商
Informa UK Limited
发表日期
2022-12-01
DOI
10.1080/14712598.2022.2154601
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CAR-NK cells for cancer immunotherapy: from bench to bedside
- (2022) Leisheng Zhang et al. Biomarker Research
- Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
- (2022) Jacob A. Myers et al. JCI Insight
- CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges
- (2022) Ayda Baghery Saghchy Khorasani et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
- (2021) Ying Gong et al. Journal of Hematology & Oncology
- CAR‐NK cell in cancer immunotherapy; A promising frontier
- (2021) Faroogh Marofi et al. CANCER SCIENCE
- CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
- (2021) Faroogh Marofi et al. Stem Cell Research & Therapy
- From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
- (2021) Hui Lu et al. Frontiers in Oncology
- Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
- (2021) Zixun Yin et al. Biomarker Research
- CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
- (2021) Pouya Safarzadeh Kozani et al. Stem Cell Research & Therapy
- FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
- (2020) Jode P Goodridge et al. BLOOD
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms
- (2020) Shaghayegh Khanmohammadi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model
- (2020) Qian Liu et al. CYTOTHERAPY
- Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer
- (2020) Casey W. Buller et al. Cancers
- MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
- (2020) Annelisa M. Cornel et al. Cancers
- CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
- (2020) Fathema Uddin et al. Frontiers in Oncology
- Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
- (2020) Takumi Kobayashi et al. BLOOD
- Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
- (2020) Benjamin H. Goldenson et al. Frontiers in Immunology
- Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study
- (2020) Kentaro Yonekura et al. Blood Advances
- 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
- (2019) Yingxi Xu et al. Journal of Hematology & Oncology
- Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
- (2019) Dean A. Lee IMMUNOLOGICAL REVIEWS
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Preservation of cell-based immunotherapies for clinical trials
- (2019) RUI LI et al. CYTOTHERAPY
- NK Cell Dysfunction and Checkpoint Immunotherapy
- (2019) Jiacheng Bi et al. Frontiers in Immunology
- NK Cell Precursors in Human Bone Marrow in Health and Inflammation
- (2019) Federica Bozzano et al. Frontiers in Immunology
- Human NK Cell Development: One Road or Many?
- (2019) Frank Cichocki et al. Frontiers in Immunology
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
- (2018) Meisam Naeimi Kararoudi et al. Jove-Journal of Visualized Experiments
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- New developments in immunotherapy for lymphoma
- (2018) Heyman Benjamin et al. Cancer Biology & Medicine
- Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
- (2018) Bokyung Min et al. Immune Network
- Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
- (2018) Michelle L. Saetersmoen et al. Seminars in Immunopathology
- Natural killer-92 cells maintain cytotoxic activity after long-term cryopreservation in novel DMSO-free media
- (2017) Shannon Pasley et al. IMMUNOLOGY LETTERS
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
- (2017) K H Chen et al. LEUKEMIA
- Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
- (2017) Kevin G. Pinz et al. Oncotarget
- Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
- (2017) Alireza Shoae-Hassani et al. Frontiers in Immunology
- Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
- (2017) Anushruti Sarvaria et al. Frontiers in Immunology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- Fas ligand and lytic granule differentially control cytotoxic dynamics of natural killer cell against cancer target
- (2016) Yanting Zhu et al. Oncotarget
- Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
- (2016) Kevin H. Chen et al. Oncotarget
- T-cell Lymphoma Epidemiology: the Known and Unknown
- (2016) Anh Phan et al. Current Hematologic Malignancy Reports
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis
- (2015) Tengfei Zhang et al. Oncotarget
- Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience
- (2015) Shannon Murray et al. Human Vaccines & Immunotherapeutics
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- NKG2D CARs as Cell Therapy for Cancer
- (2014) Charles L. Sentman et al. CANCER JOURNAL
- Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
- (2014) Y. Chu et al. Cancer Immunology Research
- Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
- (2013) Isabela Pedroza-Pacheco et al. Cellular & Molecular Immunology
- Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
- (2013) Jonathan Sitrin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer
- (2013) A. El-Gazzar et al. JOURNAL OF IMMUNOLOGY
- Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
- (2013) Katrin S. Reiners et al. MOLECULAR THERAPY
- Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
- (2012) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The predictive significance of CD20 expression in B-cell lymphomas
- (2011) Veronika Prevodnik et al. Diagnostic Pathology
- Long-Term Complications of Lymphoma and Its Treatment
- (2011) Andrea K. Ng et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- Relapse after allogeneic stem cell transplantation
- (2010) A John Barrett et al. Expert Review of Hematology
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
- (2009) M. Balsamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now